Proton Therapy

Part of the Medical Radiology book series (MEDRAD)


Dose distribution is the most powerful factor in determining the therapeutic ratio in radiation oncology. Developments in diagnostic imaging and computerized treatment planning justified the drive for increasingly conformal X-ray-based radiation therapy over the past two decades. The end of substantive improvements in X-ray dose distributions is near, however, because of the inherent problems of entrance and exit dose with X-rays. The unique pattern of dose deposition with protons has long made them a promising source for radiation therapy and recent developments in technology have made proton therapy applicable to almost all cancers. While proton therapy is likely to improve the therapeutic ratio in all radiation indications, the highest priorities currently include cancers requiring radiation doses that exceed the tolerance of critical adjacent structures and cancers of childhood and young adults, for which the inevitable entrance and exit dose of X-ray-based radiation produces a low-dose radiation bath resulting in early functional loss in most childhood tissues as well as a lifelong risk for second malignancies and other radiation-related dysfunctions. This chapter discusses the rationale, technical basis, and potential applications for proton therapy.


Dose Distribution Target Motion Treatment Planning System Relative Biologic Effectiveness Proton Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Albertini F, Hug EB, Lomax AJ (2010) The influence of the optimization starting conditions on the robustness of intensity-modulated proton therapy plans. Phys Med Biol 55:2863–2878PubMedCrossRefGoogle Scholar
  2. Ares C, Khan S, Macartain AM, Heuberger J, Goitein G, Gruber G, Lutters G, Hug EB, Bodis S, Lomax AJ (2009) Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements? Int J Radiat Oncol Biol Phys 76:685–697PubMedCrossRefGoogle Scholar
  3. Bush DA, Slater JD, Bonnet R, Cheek GA, Dunbar RD, Moyers M, Slater JM (1999) Proton-beam radiotherapy for early-stage lung cancer. Chest 116:1313–1319PubMedCrossRefGoogle Scholar
  4. Chang JY, Komaki R, Wen HY, De Gracia B, Bluett JB, McAleer MF, Swisher SG, Gillin M, Mohan R, Cox JD (2011) Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys [Epub ahead of print, 2011 Jan 18]Google Scholar
  5. Chera BS, Malyapa R, Louis D, Mendenhall WM, Li Z, Lanza DC, Yeung D, Mendenhall NP (2009a) Proton therapy for maxillary sinus carcinoma. Am J Clin Oncol 32:296–303PubMedCrossRefGoogle Scholar
  6. Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, Mendenhall NP (2009b) Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin’s lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys 75:1173–1180PubMedCrossRefGoogle Scholar
  7. Chera BS, Vargas C, Morris CG, Louis D, Flampouri S, Yeung D, Duvvuri S, Li Z, Mendenhall NP (2009c) Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 75:994–1002PubMedCrossRefGoogle Scholar
  8. Cochran DM, Yock TI, Adams JA, Tarbell NJ (2008) Radiation dose to the lens during craniospinal irradiation-an improvement in proton radiotherapy technique. Int J Radiat Oncol Biol Phys 70:1336–1342PubMedCrossRefGoogle Scholar
  9. Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD (2005) Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. Int J Radiat Oncol Biol Phys 62:1405–1411PubMedCrossRefGoogle Scholar
  10. Dearnaley DP, Sydes MR, Graham JD, Aird EG, Bottomley D, Cowan RA, Huddart RA, Jose CC, Matthews JH, Millar J, Moore AR, Morgan RC, Russell JM, Scrase CD, Stephens RJ, Syndikus I, Parmar MK (2007) Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol 8:475–487PubMedCrossRefGoogle Scholar
  11. Delaney TF, Liebsch NJ, Pedlow FX, Adams J, Dean S, Yeap BY, McManus P, Rosenberg AE, Nielsen GP, Harmon DC, Spiro IJ, Raskin KA, Suit HD, Yoon SS, Hornicek FJ (2009) Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 74:732–739PubMedCrossRefGoogle Scholar
  12. Engelsman M, Delaney TF, Hong TS (2011) Proton radiotherapy: the biological effect of treating alternating subsets of fields for different treatment fractions. Int J Radiat Oncol Biol Phys 79:616–622PubMedCrossRefGoogle Scholar
  13. Fontenot JD, Lee AK, Newhauser WD (2009) Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer. Int J Radiat Oncol Biol Phys 74:616–622PubMedCrossRefGoogle Scholar
  14. Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Li W (2002) Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans.Am Ophthalmol.Soc 100:43–48PubMedGoogle Scholar
  15. Hoffman KE, Yock TI (2009) Radiation therapy for pediatric central nervous system tumors. J Child Neurol 24:1387–1396PubMedCrossRefGoogle Scholar
  16. Hoppe BS, Flampouri S, Li Z, Mendenhall NP (2010) Cardiac sparing with proton therapy in consolidative radiation therapy for Hodgkin lymphoma. Leuk.Lymphoma 51:1559–1562PubMedCrossRefGoogle Scholar
  17. Hua C, Bass JK, Khan R, Kun LE, Merchant TE (2008) Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose. Int J Radiat Oncol Biol Phys 72:892–899PubMedCrossRefGoogle Scholar
  18. Hug EB, Sweeney RA, Nurre PM, Holloway KC, Slater JD, Munzenrider JE (2002) Proton radiotherapy in management of pediatric base of skull tumors. Int J Radiat Oncol Biol Phys 52:1017–1024PubMedCrossRefGoogle Scholar
  19. Hui Z, Zhang X, Starkschall G, Li Y, Mohan R, Komaki R, Cox JD, Chang JY (2008) Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer. Int J Radiat Oncol Biol Phys 72:1385–1395PubMedCrossRefGoogle Scholar
  20. Kawashima M, Kohno R, Nakachi K, Nishio T, Mitsunaga S, Ikeda M, Konishi M, Takahashi S, Gotohda N, Arahira S, Zenda S, Ogino T, Kinoshita T (2011) Dose-Volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 79:1479–1486PubMedCrossRefGoogle Scholar
  21. Krejcarek SC, Grant PE, Henson JW, Tarbell NJ, Yock TI (2007) Physiologic and radiographic evidence of the distal edge of the proton beam in craniospinal irradiation. Int J Radiat Oncol Biol Phys 68:646–649PubMedCrossRefGoogle Scholar
  22. Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EH, Cheung MR, Lee AK, Pollack A (2008) Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70:67–74PubMedCrossRefGoogle Scholar
  23. Lomax AJ, Goitein M, Adams J (2003) Intensity modulation in radiotherapy: photons versus protons in the paranasal sinus. Radiother Oncol 66:11–18PubMedCrossRefGoogle Scholar
  24. MacDonald SM, Safai S, Trofimov A, Wolfgang J, Fullerton B, Yeap BY, Bortfeld T, Tarbell NJ, Yock T (2008) Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons. Int J Radiat Oncol Biol Phys 71:979–986PubMedCrossRefGoogle Scholar
  25. MacDonald SM, Trofimov A, Safai S, Adams J, Fullerton B, Ebb D, Tarbell NJ, Yock TI (2011) Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes. Int J Radiat Oncol Biol Phys 79:121–129PubMedCrossRefGoogle Scholar
  26. Mendenhall WM, Amdur RJ, Morris CG, Kirwan J, Malyapa RS, Vaysberg M, Werning JW, Mendenhall NP (2009) Carcinoma of the nasal cavity and paranasal sinuses. Laryngoscope 119:899–906PubMedCrossRefGoogle Scholar
  27. Mendenhall NP, Li Z, Hoppe BS, Marcus RB, Jr, Mendenhall WM, Nichols RC, Morris CG, Williams CR, Costa J, Henderson R (2010) Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys [Epub ahead of print, 2010 Nov 17]Google Scholar
  28. Merchant TE (2009) Proton beam therapy in pediatric oncology. Cancer J 15:298–305PubMedCrossRefGoogle Scholar
  29. Merchant TE, Kiehna EN, Kun LE, Mulhern RK, Li C, Xiong X, Boop FA, Sanford RA (2006) Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J Neurosurg 104:94–102PubMedGoogle Scholar
  30. Merchant TE, Hua CH, Shukla H, Ying X, Nill S, Oelfke U (2008) Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr.Blood Cancer 51:110–117PubMedCrossRefGoogle Scholar
  31. Merchant TE, Conklin HM, Wu S, Lustig RH, Xiong X (2009) Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol 27:3691–3697PubMedCrossRefGoogle Scholar
  32. Mizumoto M, Okumura T, Hashimoto T, Fukuda K, Oshiro Y, Fukumitsu N, Abei M, Kawaguchi A, Hayashi Y, Ookawa A, Hashii H, Kanemoto A, Moritake T, Tohno E, Tsuboi K, Sakae T, Sakurai H (2010) Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols. Int J Radiat Oncol Biol Phys [Epub ahead of print, 2010 Sep 30]Google Scholar
  33. Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, Donaldson SS, Green DM, Sklar CA, Robison LL, Leisenring WM (2009) Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the childhood cancer survivor study cohort. BMJ 339:b4606PubMedCrossRefGoogle Scholar
  34. Munzenrider JE , Liebsch NJ (1999) Proton therapy for tumors of the skull base. Strahlenther Onkol 175:57–63Google Scholar
  35. Nakayama H, Sugahara S, Tokita M, Fukuda K, Mizumoto M, Abei M, Shoda J, Sakurai H, Tsuboi K, Tokuuye K (2009) Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience. Cancer 115:5499–5506PubMedCrossRefGoogle Scholar
  36. Nichols CR (2010) Protons offer reduced normal tissue exposure for patients receiving postoperative radiotherapy (RT) for resected pancreatic head cancer. 78:S332Google Scholar
  37. Peeters ST, Heemsbergen WD, Koper PC, van Putten WL, Slot A, Dielwart MF, Bonfrer JM, Incrocci L, Lebesque JV (2006) Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24:1990–1996PubMedCrossRefGoogle Scholar
  38. Pommier P, Liebsch NJ, Deschler DG, Lin DT, McIntyre JF, Barker FG, Adams JA, Lopes VV, Varvares M, Loeffler JS, Chan AW (2006) Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 132:1242–1249PubMedCrossRefGoogle Scholar
  39. Rossi CJ Jr, Slater JD, Yonemoto LT, Jabola BR, Bush DA, Levy RP, Grove R, Slater JM (2004) Influence of patient age on biochemical freedom from disease in patients undergoing conformal proton radiotherapy of organ-confined prostate cancer. Urology 64:729–732PubMedCrossRefGoogle Scholar
  40. Schoenfeld AJ, Hornicek FJ, Pedlow FX, Kobayashi W, Garcia RT, Delaney TF, Springfield D, Mankin HJ, Schwab JH (2010) Osteosarcoma of the spine: experience in 26 patients treated at the Massachusetts general hospital. Spine J 10:708–714PubMedCrossRefGoogle Scholar
  41. Sejpal S, Komaki R, Tsao A, Chang JY, Liao Z, Wei X, Allen PK, Lu C, Gillin M, Cox JD (2011) Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer. Cancer [Epub ahead of print, 2011 Jan 24]Google Scholar
  42. Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Urie MM, McManus PL, Young RH, Shipley JW, Zietman AL, Biggs PJ (1995) Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 32:3–12PubMedCrossRefGoogle Scholar
  43. Slater JD, Rossi CJ Jr, Yonemoto LT, Bush DA, Jabola BR, Levy RP, Grove RI, Preston W, Slater JM (2004) Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Radiat Oncol Biol Phys 59:348–352PubMedCrossRefGoogle Scholar
  44. Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, Joensuu T, Lynch CF, Van Leeuwen FE, Holowaty E, Storm H, Gliimelius I, Pukkala E, Stovall M, Fraumeni JF Jr, Boice JD Jr, Gilbert E (2002) Lung cancer following chemotherapy and radiotherapy for Hodgkin’s disease. J Natl Cancer Inst 94:182–192PubMedCrossRefGoogle Scholar
  45. Travis LB, Hill DA, Dores GM, Gospodarowicz M, Van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, Van’t Veer MB, Glimelius I, Storm H, Pukkala E, Stovall M, Curtis R, Boice JD Jr, Gilbert E (2003) Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA J Am Med Assoc 290:465–475CrossRefGoogle Scholar
  46. Tukenova M, Guibout C, Hawkins M, Quiniou E, Mousannif A, Pacquement H, Winter D, Bridier A, Lefkopoulos D, Oberlin O, Diallo I, de Vathaire F (2011) Radiation therapy and late mortality from second sarcoma, carcinoma, and hematological malignancies after a solid cancer in childhood. Int J Radiat Oncol Biol Phys 80:339–346PubMedCrossRefGoogle Scholar
  47. Vargas C, Fryer A, Mahajan C, Indelicato D, Horne D, Chellini A, McKenzie C, Lawlor P, Henderson R, Li Z, Lin L, Olivier K, Keole S (2008) Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 70:744–751PubMedCrossRefGoogle Scholar
  48. Weber DC, Chan AW, Lessell S, McIntyre JF, Goldberg SI, Bussiere MR, Fitzek MM, Thornton AF, Delaney TF (2006) Visual outcome of accelerated fractionated radiation for advanced sinonasal malignancies employing photons/protons. Radiother Oncol 81:243–249PubMedCrossRefGoogle Scholar
  49. Yock T, Schneider R, Friedmann A, Adams J, Fullerton B, Tarbell N (2005) Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys 63:1161–1168PubMedCrossRefGoogle Scholar
  50. Zietman AL, Bae K, Slater JD, Shipley WU, Efstathiou JA, Coen JJ, Bush DA, Lunt M, Spiegel DY, Skowronski R, Jabola BR, Rossi CJ (2010) Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95–09. J Clin Oncol 28:1106–1111PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  1. 1.University of Florida Proton InstituteJacksonvilleUSA

Personalised recommendations